Northpointe Capital’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-426,849
| Closed | -$5.43M | – | 254 |
|
|
2015
Q1 | $5.43M | Sell |
426,849
-87,596
| -17% | -$1.12M | 0.59% | 53 |
|
|
2014
Q4 | $7.28M | Buy |
514,445
+49,650
| +11% | +$703K | 0.87% | 30 |
|
|
2014
Q3 | $6.39M | Sell |
464,795
-427,216
| -48% | -$5.87M | 0.68% | 60 |
|
|
2014
Q2 | $13.7M | Buy |
892,011
+14,136
| +2% | +$217K | 1.32% | 7 |
|
|
2014
Q1 | $15M | Sell |
877,875
-411,836
| -32% | -$7.02M | 1.52% | 9 |
|
|
2013
Q4 | $16.7M | Buy |
1,289,711
+228,285
| +22% | +$2.96M | 1.47% | 14 |
|
|
2013
Q3 | $10.7M | Sell |
1,061,426
-43,840
| -4% | -$443K | 1.26% | 21 |
|
|
2013
Q2 | $8.26M | Buy |
+1,105,266
| New | +$8.26M | 0.95% | 32 |
|